Coronary CT Angiography Guided Medical Therapy in Subclinical Atherosclerosis

Total Page:16

File Type:pdf, Size:1020Kb

Coronary CT Angiography Guided Medical Therapy in Subclinical Atherosclerosis Journal of Clinical Medicine Review Coronary CT Angiography Guided Medical Therapy in Subclinical Atherosclerosis Alyssa L. S. Chow 1,2, Saad D. Alhassani 2, Andrew M. Crean 2 and Gary R. Small 2,* 1 Royal College of Surgeons in Ireland, Dublin 2, Ireland; [email protected] 2 Department of Medicine University of Ottawa, Division of Cardiology, Ottawa, ON K1Y 4W7, Canada; [email protected] (S.D.A.); [email protected] (A.M.C.) * Correspondence: [email protected]; Tel.: +1-613-696-7279 Abstract: The goals of primary prevention in coronary atherosclerosis are to avoid sudden cardiac death, myocardial infarction or the need for revascularization procedures. Successful prevention will rely on accurate identification, effective therapy and monitoring of those at risk. Identification and potential monitoring can be achieved using cardiac computed tomography (CT). Cardiac CT can determine coronary artery calcification (CAC), a useful surrogate of coronary atherosclerosis burden. Cardiac CT can also assess coronary CT angiography (CCTA). CCTA can identify arterial lumen narrowing and highlight mural atherosclerosis hitherto hidden from other anatomical approaches. Herein we consider the role of CCTA and CAC-scoring in subclinical atherosclerosis. We explore the use of these modalities in screening and discuss data that has used CCTA for guiding primary prevention. We examine therapeutic trials using CCTA to determine the effects of plaque-modifying therapies. Finally, we address the role of CCTA and CAC to guide therapy as defined in current primary prevention documents. CCTA has emerged as an essential tool in the detection and man- agement of clinical coronary artery disease. To date, its role in subclinical atherosclerosis is less well defined, yet with modern CT scanners and continued pharmacotherapy development, CCTA is likely Citation: Chow, A.L.S.; Alhassani, to achieve a more prominent place in the primary prevention of coronary atherosclerosis. S.D.; Crean, A.M.; Small, G.R. Coronary CT Angiography Guided Keywords: primary prevention; atherosclerosis; coronary CT angiography Medical Therapy in Subclinical Atherosclerosis. J. Clin. Med. 2021, 10, 625. https://doi.org/10.3390/ jcm10040625 1. Introduction Academic Editor: Michael Henein The first Chinese medical text (2600BC) foresightedly taught, “Inferior doctors treat Received: 31 December 2020 the full-blown disease, mediocre doctors treat the disease before evident, superior doctors Accepted: 1 February 2021 prevent the disease” [1]. Although as medical practitioners, we might not enjoy the im- Published: 7 February 2021 plications of the statement, there is wisdom in the saying that still holds true today. In healthcare we most commonly focus on symptomatic patients, often neglecting a popula- Publisher’s Note: MDPI stays neutral tion who may benefit from preventative treatment. This approach, however, is changing. with regard to jurisdictional claims in Increasingly, across medical specialties, we are witnessing advances in technology and published maps and institutional affil- imaging that present unprecedented opportunities to intervene before overt symptomatic iations. disease occurs [2]. This is especially so in cardiovascular disease, which remains a leading cause of death worldwide, claiming 17.9 million lives per year [3] of which approximately 50% of cases are attributed to coronary heart disease [4]. To address this need, coronary CT angiography Copyright: © 2021 by the authors. (CCTA) has gradually emerged over 20 years as an important diagnostic tool and begun to Licensee MDPI, Basel, Switzerland. impact disease prevention [5–8]. It readily identifies both obstructive and non-obstructive This article is an open access article coronary artery atherosclerotic plaque which is the forerunner of coronary artery disease distributed under the terms and (CAD) [9–11]. Not only does CCTA identify the presence of atherosclerotic plaque, it conditions of the Creative Commons accurately risk-stratifies patients at risk of suffering coronary atherosclerotic events [12,13]. Attribution (CC BY) license (https:// Thus, as we work to have CCTA employed in primary prevention, we strive to become the creativecommons.org/licenses/by/ ‘superior’ doctors outlined by ancient Chinese wisdom. 4.0/). J. Clin. Med. 2021, 10, 625. https://doi.org/10.3390/jcm10040625 https://www.mdpi.com/journal/jcm J. Clin. Med. 2021, 10, x FOR PEER REVIEW 2 of 14 J. Clin. Med. 2021, 10, 625 2 of 14 In this review we consider the definition of subclinical atherosclerosis, the pathogen- esis of atherosclerosis, its prevalence and current recommendations for atherosclerosis In this review we consider the definition of subclinical atherosclerosis, the pathogen- esisscreening. of atherosclerosis, We look at its t prevalencehe application and currentof cardiac recommendations CT in primary for prevention atherosclerosis by assessing screening.how it: (a) We refines look atrisk the prediction, application ( ofb) cardiacis employed CT in primaryto investigate prevention treatment by assessing, and (c) directs howtherapy it: (a) in refines primary risk prediction,prevention (b) guidelines. is employed to investigate treatment, and (c) directs therapy in primary prevention guidelines. 2. Subclinical versus Clinical Atherosclerosis 2. Subclinical versus Clinical Atherosclerosis Atherosclerosis is defined as an area in the intima layer of an artery that is lipid rich, Atherosclerosis is defined as an area in the intima layer of an artery that is lipid rich, contains cellular debris, lipid-laden cells, and inflammatory cells and is often calcified contains cellular debris, lipid-laden cells, and inflammatory cells and is often calcified (Figure(Figure1)[ 1)14 [14].]. Clinical Clinical obstructive obstructive atherosclerosis atherosclerosisdevelops develops when thiswhen area this encroaches area encroaches upon upon 50%50% or or more more of theof the vessel vessel lumen lumen and causesand causes ischemic ischemic symptoms. symptoms. Alternatively, Alternatively,clinical clinical non-obstructivenon-obstructive atherosclerosis atherosclerosismay may also also exist exist in the in the absence absence of a of 50% a 50% luminal luminal narrowing narrowing but butfollowing following an an acute acute plaque plaque event thatthat has has presented presented as anas acutean acute coronary coronary syndrome. syndrome. In Incontrast, contrast, subclinicalsubclinical atherosclerosis atherosclerosis isis characterisedcharacterised by by the the presence presence of asymptomaticof asymptomatic non- non-obstructiveobstructive or orobstructive obstructive atherosclerosis. atherosclerosis. FigureFigure 1. 1.Schematic Schematic representation representation of atherogenesis. of atherogenesis. Atherosclerosis Atherosclerosis develops develops from the secondfrom the and second thirdand decadethird decade of life onwards of life onwards in Western in populations Western populations and is characterized and is bycharacterized the gradual accumulation by the gradual accu- ofmulation lipid-rich of material lipid-rich within material the intimal within layer the of intimal arteries layer (Figure of adapted arteries from (Figure [14]). adapted from [14]). 3.3. Prevalence Prevalence of of Subclinical Subclinical Atherosclerosis Atherosclerosis Subclinical atherosclerosis occurs usually in the second and third decades of life in Subclinical atherosclerosis occurs usually in the second and third decades of life in individuals from developed countries [15]. Its development is thought to reflect genetic, nutritionalindividuals and from cultural developed factors [countries16,17]. The [15 disease]. Its development traditionally progresses is thought slowly to reflect for genetic, decadesnutritional before and the cultural onset of factors symptoms. [16,17 Determining]. The disease prevalence traditionally of a subclinical progresses condition slowly for dec- canades be before challenging; the onset autopsy of symptoms. data from AmericanDetermining soldiers prevalence who died of in a combatsubclinical has beencondition can instructivebe challenging; to assess autopsy the presence data of from atherosclerosis American and soldiers to track who the changesdied in incombat the pattern has been in- ofstructive disease over to assess time [ 18the]. presence of atherosclerosis and to track the changes in the pattern of diseasePrevalence over in time the young [18]. has declined over the past 60–70 years. Atherosclerosis was foundPrevalence in 77% of Korean in the war young American has declined casualties, over 45% the of those past from60–70 the years. Vietnam Atherosclerosis war, and was 12% in those who died in combat between 2001 and 2011 [18–20]. The decline speaks to the found in 77% of Korean war American casualties, 45% of those from the Vietnam war, and success of health behaviour and primary prevention programs [18]. 12% in those who died in combat between 2001 and 2011 [18–20]. The decline speaks to the success of health behaviour and primary prevention programs [18]. The prevalence of subclinical atherosclerosis in middle and older age was studied in the Multi-Ethnic Study of Atherosclerosis (MESA) study [21]. MESA recruited 6814 par- J. Clin. Med. 2021, 10, 625 3 of 14 The prevalence of subclinical atherosclerosis in middle and older age was studied in the Multi-Ethnic Study of Atherosclerosis (MESA) study [21]. MESA recruited 6814 participants aged 45–84 years without known cardiovascular disease and underwent coronary calcium
Recommended publications
  • Cardiac CT - Quantitative Evaluation of Coronary Calcification
    Clinical Appropriateness Guidelines: Advanced Imaging Appropriate Use Criteria: Imaging of the Heart Effective Date: January 1, 2018 Proprietary Date of Origin: 03/30/2005 Last revised: 11/14/2017 Last reviewed: 11/14/2017 8600 W Bryn Mawr Avenue South Tower - Suite 800 Chicago, IL 60631 P. 773.864.4600 Copyright © 2018. AIM Specialty Health. All Rights Reserved www.aimspecialtyhealth.com Table of Contents Description and Application of the Guidelines ........................................................................3 Administrative Guidelines ........................................................................................................4 Ordering of Multiple Studies ...................................................................................................................................4 Pre-test Requirements ...........................................................................................................................................5 Cardiac Imaging ........................................................................................................................6 Myocardial Perfusion Imaging ................................................................................................................................6 Cardiac Blood Pool Imaging .................................................................................................................................12 Infarct Imaging .....................................................................................................................................................15
    [Show full text]
  • Assessment of the Coronary Artery in High-Pitch, Dual-Source CT
    CARDIAC IMAGING Iran J Radiol. 2017 July; 14(3):e22024. doi: 10.5812/iranjradiol.22024. Published online 2017 July 1. Research Article Assessment of the Coronary Artery in High-Pitch, Dual-Source CT Aortography Without ECG Synchronization Hyeong Gi Choi,1 Mi Jung Park,1,* Ho Cheol Choi,1 Hye Young Choi,1 Hwa Seon Shin,1 Jae Boem Na,1 Jae Min Cho,1 and Dae Seob Choi1 1Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Chilam-Dong, Jinju City, Gyeongnam-Do, Republic of Korea *Corresponding author: Mi Jung Park, MD, Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, 90, Chilam-Dong, Jinju, Gyeongnam-Do, Republic of Korea. Tel: +82-557508814, Fax: +82-557581568, E-mail: [email protected] Received 2016 December 22; Revised 2017 March 17; Accepted 2017 April 01. Abstract Background: The high pitch, dual source computed tomography (CT) provides motion-free aortic imaging. Objectives: To evaluate the image quality of coronary artery using dual-source CT aortography without electrocardiogram (ECG) synchronization. Patients and Methods: One hundred fifty patients (87 men; mean age; 63.7 ± 13.0 years, mean heart rate; 64.7 ± 6.6 beats/min) with suspected or known aortic disease underwent non-ECG gated, high-pitch, dual-source CT aortography. No beta blocker or ni- troglycerin was administered for the patients. The image quality of each coronary artery segment and its ostium was graded on a three-point scale (excellent, moderate, and non-diagnostic image quality). Results: Most patients (88.7%) showed diagnostic image quality in the ostia of the left main and right coronary artery.
    [Show full text]
  • Prevalence of Coronary Artery Disease Evaluated by Coronary CT Angiography in Women with Mammographically Detected Breast Arterial Calcifications
    RESEARCH ARTICLE Prevalence of Coronary Artery Disease Evaluated by Coronary CT Angiography in Women with Mammographically Detected Breast Arterial Calcifications Leila Mostafavi1*, Wanda Marfori2, Cesar Arellano1, Alessia Tognolini1, William Speier3, Ali Adibi1, Stefan G. Ruehm1 1 Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America, 2 Department of Radiological Sciences, University of California Irvine, Irvine, CA, United States of America, 3 Medical Imaging Informatics, Department of Radiological Sciences, University of California Los Angeles, Los Angeles, CA, United States of America * [email protected] Abstract To assess the correlation between breast arterial calcifications (BAC) on digital mammogra- OPEN ACCESS phy and the extent of coronary artery disease (CAD) diagnosed with dual source coronary Citation: Mostafavi L, Marfori W, Arellano C, computed tomography angiography (CTA) in a population of women both symptomatic and Tognolini A, Speier W, Adibi A, et al. (2015) asymptomatic for coronary artery disease. 100 consecutive women (aged 34 – 86 years) Prevalence of Coronary Artery Disease Evaluated by who underwent both coronary CTA and digital mammography were included in the study. Coronary CT Angiography in Women with Mammographically Detected Breast Arterial Health records were reviewed to determine the presence of cardiovascular risk factors such Calcifications. PLoS ONE 10(4): e0122289. as hypertension, hyperlipidemia, diabetes mellitus, and smoking. Digital mammograms doi:10.1371/journal.pone.0122289 were reviewed for the presence and degree of BAC, graded in terms of severity and extent. Academic Editor: Barry I Hudson, University of Coronary CTAs were reviewed for CAD, graded based on the extent of calcified and non- Miami, UNITED STATES calcified plaque, and the degree of major vessel stenosis.
    [Show full text]
  • ACR Manual on Contrast Media
    ACR Manual On Contrast Media 2021 ACR Committee on Drugs and Contrast Media Preface 2 ACR Manual on Contrast Media 2021 ACR Committee on Drugs and Contrast Media © Copyright 2021 American College of Radiology ISBN: 978-1-55903-012-0 TABLE OF CONTENTS Topic Page 1. Preface 1 2. Version History 2 3. Introduction 4 4. Patient Selection and Preparation Strategies Before Contrast 5 Medium Administration 5. Fasting Prior to Intravascular Contrast Media Administration 14 6. Safe Injection of Contrast Media 15 7. Extravasation of Contrast Media 18 8. Allergic-Like And Physiologic Reactions to Intravascular 22 Iodinated Contrast Media 9. Contrast Media Warming 29 10. Contrast-Associated Acute Kidney Injury and Contrast 33 Induced Acute Kidney Injury in Adults 11. Metformin 45 12. Contrast Media in Children 48 13. Gastrointestinal (GI) Contrast Media in Adults: Indications and 57 Guidelines 14. ACR–ASNR Position Statement On the Use of Gadolinium 78 Contrast Agents 15. Adverse Reactions To Gadolinium-Based Contrast Media 79 16. Nephrogenic Systemic Fibrosis (NSF) 83 17. Ultrasound Contrast Media 92 18. Treatment of Contrast Reactions 95 19. Administration of Contrast Media to Pregnant or Potentially 97 Pregnant Patients 20. Administration of Contrast Media to Women Who are Breast- 101 Feeding Table 1 – Categories Of Acute Reactions 103 Table 2 – Treatment Of Acute Reactions To Contrast Media In 105 Children Table 3 – Management Of Acute Reactions To Contrast Media In 114 Adults Table 4 – Equipment For Contrast Reaction Kits In Radiology 122 Appendix A – Contrast Media Specifications 124 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions.
    [Show full text]
  • 2012-Nia-Clinical-Guidelines-Avmed
    2012 NIA Standard Clincal Guidelines AvMed Guidelines for Clinical Review Determination Preamble NIA is committed to the philosophy of supporting safe and effective treatment for patients. The medical necessity criteria that follow are guidelines for the provision of diagnostic imaging. These criteria are designed to guide both providers and reviewers to the most appropriate diagnostic tests based on a patient‘s unique circumstances. In all cases, clinical judgment consistent with the standards of good medical practice will be used when applying the guidelines. Guideline determinations are made based on the information provided at the time of the request. It is expected that medical necessity decisions may change as new information is provided or based on unique aspects of the patient‘s condition. The treating clinician has final authority and responsibility for treatment decisions regarding the care of the patient. Guideline Development Process These medical necessity criteria were developed by NIA for the purpose of making clinical review determinations for requests for diagnostic tests. The developers of the criteria sets included representatives from the disciplines of radiology, internal medicine, nursing, and cardiology. They were developed following a literature search pertaining to established clinical guidelines and accepted diagnostic imaging practices. All inquiries should be directed to: National Imaging Associates, Inc. 6950 Columbia Gateway Drive Columbia, MD 21046 Attn: NIA Associate Chief Medical Officer 2011 National
    [Show full text]
  • Cardiac PET and PET/CT Imaging
    Cardiac PET and PET/CT Imaging M. F. Di Carli and M. J. Lipton, eds. New York, NY: Springer, 2007, 466 pages, $149 Cardiac PET and PET/CT Imaging is a comprehensive, therapy. Chapters 17, 18, and 21 are a must-read for clini- informative, up-to-date, state-of-the-art textbook on newer cal PET, whereas chapters 23 through 26 are informative cardiac imaging technologies and also provides valuable and useful regarding ongoing research and will help one insight into the future of cardiac imaging. The book has 6 keep up with future developments in this evolving field. parts; the first 5 parts or sections are subdivided into several Part 6 comprises multiple case presentations with good chapters that cover a wide spectrum of presently available illustrations and good explanations of image findings, and newer cardiac imaging modalities and future research goals. many are supported with additional relevant correlations or The first 3 parts progress in a systematic and orderly manner, follow-up findings. There are 18 diverse illustrative cases, starting with the basics of PET instrumentation, the princi- including normal study findings, misregistration and atten- ples of PET, PET tracers and radiopharmaceuticals, CT uation correction artifacts, incidental findings, abnormal cardiac anatomy, iodinated contrast agents, radiation safety, high-risk PET/CT scans, myocardial viability, integrated patient preparation, stress protocols, PET and PET/CT pro- myocardial perfusion with assessment of coronary artery tocols, myocardial PET interpretation, and PET quantifica- calcium score, left ventricular function assessment, and CT tion for assessing preclinical coronary artery disease. The coronary angiography. The writing is clear and understand- relative merits of coronary CT angiography and MRI along able; even difficult topics such as physics, radiochemistry, with integrated assessment of myocardial perfusion using and biochemistry are well presented and are understandable coronary angiography and PET/CT for diagnosing and man- with concentrated reading.
    [Show full text]
  • Corrected Coronary Opacification Decrease from Coronary Computed
    ORIGINAL ARTICLE Corrected coronary opacification decrease from coronary computed tomography angiography: Validation with quantitative 13N-ammonia positron emission tomography Dominik C. Benz, MD,a Christoph Gra¨ni, MD,a Paola Ferro, MD,a Luis Neumeier,a Michael Messerli, MD,a Mathias Possner, MD,a Olivier F. Clerc, MD,a Catherine Gebhard, MD,a Oliver Gaemperli, MD,a Aju P. Pazhenkottil, MD,a Philipp A. Kaufmann, MD,a and Ronny R. Buechel, MDa a Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland Received Mar 25, 2017; accepted Jun 7, 2017 doi:10.1007/s12350-017-0980-2 Background. To assess the functional relevance of a coronary artery stenosis, corrected coronary opacification (CCO) decrease derived from coronary computed tomography angiography (CCTA) has been proposed. The present study aims at validating CCO decrease with quantitative 13N-ammonia positron emission tomography (PET) myocardial perfusion imaging (MPI). Methods and Results. This retrospective study consists of 39 patients who underwent hybrid CCTA/PET-MPI. From CCTA, attenuation in the coronary lumen was measured before and after a stenosis and corrected to the aorta to calculate CCO and its decrease. Relative flow reserve (RFR) was calculated by dividing the stress myocardial blood flow (MBF) of a vessel territory subtended by a stenotic coronary by the stress MBF of the reference territories without stenoses. RFR was abnormal in 11 vessel territories (27%). CCO decrease yielded a sensitivity, specificity, negative predictive value, positive predictive value, and accuracy for prediction of an abnormal RFR of 73%, 70%, 88%, 47%, and 70%, respectively. Conclusions. CCTA-derived CCO decrease has moderate diagnostic accuracy to predict an abnormal RFR in PET-MPI.
    [Show full text]
  • American College of Radiology – Practice Parameter for Cardiac CT
    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. Revised 2021 (Resolution 45)* ACR–NASCI–SPR PRACTICE PARAMETER FOR THE PERFORMANCE AND INTERPRETATION OF CARDIAC COMPUTED TOMOGRAPHY (CT) PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
    [Show full text]
  • Iodinated Contrast Media Guideline
    IODINATED CONTRAST MEDIA GUIDELINE FACULTY OF CLINICAL RADIOLOGY THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF RADIOLOGISTS® Name of document and version: Iodinated Contrast Media Guideline, V2.3 Approved by: Faculty of Clinical Radiology Date of approval: March 2018 Suggested Citation: The Royal Australian and New Zealand College of Radiologists. Iodinated Contrast Media Guideline. Sydney: RANZCR; 2018. ABN 37 000 029 863 Copyright for this publication rests with The Royal Australian and New Zealand College of Radiologists ® The Royal Australian and New Zealand College of Radiologists Level 9, 51 Druitt Street Sydney NSW 2000 Australia Email: [email protected] Website: www.ranzcr.edu.au Telephone: +61 2 9268 9777 Disclaimer: The information provided in this document is of a general nature only and is not intended as a substitute for medical or legal advice. It is designed to support, not replace, the relationship that exists between a patient and his/her doctor. Document name Iodinated Contrast Media Guideline Description The Iodinated Contrast Media Guideline is intended to assist The Royal Australian and New Zealand College of Radiologists®, its staff, Fellows, members and other individuals involved in the administration of iodinated contrast media to patients undergoing medical imaging procedures. Created By Standards of Practice and Accreditation Committee Date Created 2011 Maintained By Faculty of Clinical Radiology, Policy and Advocacy Unit Version Number Modifications Made Date Modified 2011 Document published 2.0 Document updated and published April 2016 2.1 Grammatical error corrected in R31 February 2017 2.2 Nitroglycerin dosages corrected in R39 June 2017 2.3 Adrenaline dosage corrected in R56 March 2018 Iodinated Contrast Media Guideline, V2.3 © The Royal Australian and New Zealand College of Radiologists® March 2018 Page 2 of 39 TABLE OF CONTENTS 1.
    [Show full text]
  • RAC Annual Report 2009
    THE ANNUAL REPORT OF THE RADIATION ADVISORY COMMITTEE FOR THE FINANCIAL YEAR ENDING JUNE 2009 RADIATION ADVISORY COMMITTEE ANNUAL REPORT 2009 ii RADIATION ADVISORY COMMITTEE ANNUAL REPORT 2009 RADIATION ADVISORY COMMITTEE Melbourne, Australia State of Victoria 2009 ISBN 1035-7912 This document is available on-line at: www.health.vic.gov.au/environment/radiation/committee.htm iii RADIATION ADVISORY COMMITTEE ANNUAL REPORT 2009 Daniel Andrews MLA Minister for Health Dear Minister Pursuant to Section 110 of the Radiation Act 2005, the Radiation Advisory Committee submits the 2009 annual report of the Committee for presentation to Parliament. Yours faithfully Dr John Heggie Chair RADIATION ADVISORY COMMITTEE iv RADIATION ADVISORY COMMITTEE ANNUAL REPORT 2009 CONTENTS RADIATION ADVISORY COMMITTEE ...................................................................1 (i) Composition........................................................................................................................ 1 (ii) Responsibilities................................................................................................................... 5 1. INTRODUCTION .........................................................................6 2. IONISING RADIATION...............................................................6 2.1 Research involving irradiation of human volunteers ......................................................... 6 2.2 Radiation incidents............................................................................................................
    [Show full text]
  • Extremely Rare Single Right Coronary Artery, Multidetector Computed
    Arch Cardiol Mex 2012;82(2):195-196 www.elsevier.com.mx IMAGE IN CARDIOLOGY Extremely rare single right coronary artery: multidetector com- puted tomography indings Mauro Echavarría-Pinto, Engels Rodríguez-Rodríguez, Enrico Macías, Eric Kimura- Hayama. Department of Radiology. Instituto Nacional de Cardiología Ignacio Chávez. Mexico City, Mexico. Received on September 9, 2011; accepted on December 9, 2011. KAYWORDS Abstract Coronary anomalies; Mul- Coronary anomalies are rare, with a reported prevalence of 1.3% among patients who undergo tidetector computed to- coronary angiography. The great majority of coronary a rtery anomalies are incidental indings mography; Single right and are not clinically signiicant, but in some cases , may be responsible for angina, syncope, coronary artery; Mexico. arrhythmias or even sudden death. In the following case, we describe coronary CT angiography indings of one of the rarest coronary anomalies. Lip ton R-I type single right coronary artery has only been previously reported in very few occasions and has been seen in only 0.0007% of the population. PALABRAS CLAVE Arteria coronaria derecha única muy infrecuente: hallazgos por tomografía computada Anomalías coronarias; To- multidetector mografía computada mul- ticorte; Arteria coronaria Resumen derecha única; México. Las anomalías congénitas de las arterias coronarias son raras, con una prevalencia estimada de 1.3% en pacientes sometidos a angiografía coronaria. La gran mayoría de estas anomalías no son clínicamente signiicativas, aunque en algunos casos, pueden producir angina, sínco- pe, arritmias e incluso muerte súbita. En el siguiente caso, describimos mediante tomografía computarizada multicorte, una de las anomalías congénitas de las arterias coronarias más raras. La arteria coronaria derecha única tipo R-Ie dLipton, de la que sólo se han reportado muy pocos casos y su prevalencia se estima en 0.0007%.
    [Show full text]
  • High-Pitch Versus Conventional Cardiovascular CT in Patients Being Assessed for Transcatheter Aortic Valve Implantation: a Real-World Appraisal
    Open Access Aortic and vascular disease Open Heart: first published as 10.1136/openhrt-2017-000626 on 8 August 2017. Downloaded from High-pitch versus conventional cardiovascular CT in patients being assessed for transcatheter aortic valve implantation: a real-world appraisal Tevfik F Ismail,1 Emma Cheasty,2 Laurence King,3 Sahar Naaseri,2 Olga Lazoura,2 Natalie Gartland,2 Simon Padley,2,4 Michael B Rubens,2,4 Isabel Castellano,3,4 Edward D Nicol2,4 To cite: Ismail TF, Cheasty E, ABSTRACT KEY QUESTIONS King L, et al. High-pitch versus Objective High-pitch protocols are increasingly used in conventional cardiovascular cardiovascular CT assessment for transcatheter aortic CT in patients being assessed What is already known about this subject? valve implantation (TAVI), but the impact on diagnostic for transcatheter aortic Gated cardiovascular CT can be used to evaluate image quality is not known. valve implantation: a real- the aorta and the coronary arteries in patients being Methods We reviewed 95 consecutive TAVI studies: 44 world appraisal. Open Heart considered for transcatheter aortic valve implantation. (46%) high-pitch and 51 (54%) standard-pitch. Single 2017;4:e000626. doi:10.1136/ It is not known whether newer high-pitch acquisition openhrt-2017-000626 high-pitch scans were performed regardless of heart protocols perform as well as standard-pitch rate. For standard-pitch acquisitions, a separate CT- approaches for coronary and aortic evaluation. aortogram and CT-coronary angiogram were performed TI and EC contributed equally with prospective gating, unless heart rate was ≥70 beats/ and are joint first author What does this study add? min, when retrospective gating was used.
    [Show full text]